ID Database Citation 12891546 Pubmed "Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Gastroenterology. 2003 Aug;125(2):437–43. PubMed Europe PMC Scholia" 16364488 Pubmed "Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? Larter CZ, Farrell GC. J Hepatol. 2006 Feb;44(2):253–61. PubMed Europe PMC Scholia" 18242193 Pubmed "Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Free Radic Biol Med. 2008 Apr 1;44(7):1259–72. PubMed Europe PMC Scholia" 19352614 Pubmed "Molecular mechanisms involved in NAFLD progression. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. J Mol Med (Berl). 2009 Jul;87(7):679–95. PubMed Europe PMC Scholia" 20303879 Pubmed "Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Hotamisligil GS. Cell. 2010 Mar 19;140(6):900–17. PubMed Europe PMC Scholia" 21145844 Pubmed "Endoplasmic reticulum stress in liver disease. Malhi H, Kaufman RJ. J Hepatol. 2011 Apr;54(4):795–809. PubMed Europe PMC Scholia" 22570745 Pubmed "NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Farrell GC, van Rooyen D, Gan L, Chitturi S. Gut Liver. 2012 Apr;6(2):149–71. PubMed Europe PMC Scholia" 22705006 Pubmed "A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Seki E, Brenner DA, Karin M. Gastroenterology. 2012 Aug;143(2):307–20. PubMed Europe PMC Scholia" 25501551 Pubmed "Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis. Dattaroy D, Pourhoseini S, Das S, Alhasson F, Seth RK, Nagarkatti M, et al. Am J Physiol Gastrointest Liver Physiol. 2015 Feb 15;308(4):G298-312. PubMed Europe PMC Scholia" 28983452 Pubmed "Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis. Armstrong LE, Guo GL. Curr Pharmacol Rep. 2017 Apr;3(2):92–100. PubMed Europe PMC Scholia" 30315846 Pubmed "Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells. Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, et al. Cancer Lett. 2019 Jan;440–441:82–93. PubMed Europe PMC Scholia"